<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02454309</url>
  </required_header>
  <id_info>
    <org_study_id>H15-00892</org_study_id>
    <nct_id>NCT02454309</nct_id>
  </id_info>
  <brief_title>Cranberry for the Prevention of Urinary Tract Infections</brief_title>
  <official_title>A Randomised, Double-blind, Placebo Controlled Trial Evaluating the Effectiveness of a Cranberry Concentrate (CranrichTM) in Preventing Recurrent Urinary Tract Infections in Adult Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to determine whether a cranberry concentrate reduces recurrent urinary tract&#xD;
      infections (UTIs) in women. Approximately 150 adult women will be recruited to participate in&#xD;
      this study. Subjects will be randomized to either the cranberry supplement or placebo&#xD;
      treatment for 12 months. Subjects and investigators will be blinded to which supplement they&#xD;
      are taking.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be randomized to receive either a cranberry concentrate or placebo.&#xD;
      Participants, study staff and investigators will remain blinded until after the dataset has&#xD;
      been cleaned. At the baseline visit participants will be instructed to consume the assigned&#xD;
      supplement twice daily for 12 consecutive months. A calendar will be provided to record&#xD;
      compliance, recurrent UTIs and any side effects. Participants will be phoned/texted each&#xD;
      month to encourage participation. Additional study visits will be completed at 3 months, 6&#xD;
      months and 9 months to collect information on recurrent UTIs and adherence. A urine sample&#xD;
      will be collected from participants at each visit to test for pregnancy and the presence of&#xD;
      an undetected UTI. Supplements will be distributed at each visit for the following 3-month&#xD;
      study period and the last bottle of unused product returned. At the 12-month visit,&#xD;
      participants will complete an end-line questionnaire and return their supplement bottle in&#xD;
      addition to the calendar and side effect diary. If participants withdraw from the study, they&#xD;
      will be encouraged to return at 12 months to complete a survey to allow for intent-to-treat&#xD;
      analysis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of urinary tract infections</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Urinary Tract Infection</condition>
  <arm_group>
    <arm_group_label>Cranberry concentrate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each capsule contains 500 mg of cranberry powder at a concentration ratio of 36:1 (36 grams of cranberries equals 1 gram of concentrate)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A capsule containing control formulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cranberry concentrate</intervention_name>
    <arm_group_label>Cranberry concentrate</arm_group_label>
    <other_name>Cranrich (â„¢)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Females who have had at least 2 clinical-diagnosed symptomatic UTIs in the year&#xD;
             preceding&#xD;
&#xD;
          -  Can communicate in English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current UTI&#xD;
&#xD;
          -  Pregnant or breastfeeding or planning a pregnancy in the next 12 months&#xD;
&#xD;
          -  known allergy or intolerance to cranberry-containing products&#xD;
&#xD;
          -  A history of renal stones and/or renal transplantation&#xD;
&#xD;
          -  Any immunosuppressive disease or other medical conditions that could potentially&#xD;
             interfere with outcomes&#xD;
&#xD;
          -  Current use of corticosteroid, anticoagulant, antidepressants or mood stabilizing&#xD;
             medications or other medications that may interact with the supplement&#xD;
&#xD;
          -  Intermittent or indwelling catheterization&#xD;
&#xD;
          -  Any anatomic abnormalities of the urinary tract&#xD;
&#xD;
          -  The use of any antibiotics within 2 weeks before study entry&#xD;
&#xD;
          -  The use of any natural health products, including herbs, homeopathic products, or&#xD;
             other forms of cranberry supplements within 2 weeks before study entry&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sarah J Harvey, MSc</last_name>
    <phone>6047542245</phone>
    <email>sarah.harvey@ubc.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>The University of British Columbia</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6T 1Z4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Tim Green, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <study_first_submitted>May 22, 2015</study_first_submitted>
  <study_first_submitted_qc>May 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 27, 2015</study_first_posted>
  <last_update_submitted>May 30, 2016</last_update_submitted>
  <last_update_submitted_qc>May 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Urinary Tract Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

